Agnes I. Veldkamp

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

Agnes I. Veldkamp, Gerrit Jan Weverling, Joep M. A. Lange et al. · AIDS · 2001 · 207 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

Rolf P. G. van Heeswijk, Agnes I. Veldkamp, Jan W. Mulder et al. · AIDS · 2000 · 133 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

Rolf P. G. van Heeswijk, Agnes I. Veldkamp, Richard M. W. Hoetelmans et al. · AIDS · 1999 · 107 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

Agnes I. Veldkamp, Rolf P. G. van Heeswijk, Pieter L. Meenhorst et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 66 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Ritonavir Enables Combined Therapy with Rifampin and Saquinavir

Agnes I. Veldkamp, Richard M. W. Hoetelmans, J. H. Beijnen et al. · Clinical Infectious Diseases · 1999 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5